3P Biopharmaceuticals

3P.jpg

Contact information

3P Biopharmaceuticals, SL
Dámaso Molero, Director General
Polígono Mocholí, C/ Mocholí nº 2
Noáin
Navarra
948346480
948346702
Areas of activities
  • A. Health Biotechnology
    • Areas of activity
      • Biodrugs
      • Stem cells
      • Cell cultures and mantenance
      • In vitro diagnostics
      • Drug development
      • Cellular Therapy
      • Gene Therapy
      • Biomaterials and tissue therapy
      • Vaccines
  • B. Agrifood Biotechnology
    • Agriculture / veterinary / environmental
      • Animal health / Veterinary
  • C. Industrial Biotechnology
    • Enzymes
    • Fermentation or biocatalysis
    • Cell lines
    • Microorganism
    • Monomers and polymers
    • Resins to purification
  • D. Services
    • R&D services
      • Pharmacogenomics
      • CRO / CMO / SMO
    • Professional services

3P Biopharmaceuticals is a European-based Contract Development and Manufacturing Organization (CDMO) specialized in the development and GMP manufacturing of biopharmaceutical and advanced therapy products from early stages (POC, PC) up to clinical and commercial.

The company offers an integral service for the development and manufacturing of biopharmaceutical products obtained from either microbial fermentation and mammalian cell culture.

Moreover, manufacturing related services such as analytical method development and validation, stability studies, working and master cell banks (MCB/WCB) manufacturing and characterization, formulation, cell bank storage and advanced therapy services are offered.

Products and services

3P Biopharmaceuticals is equipped to handle:

New Biological Entities (NBEs)

  • Recombinant proteins
  • Vaccines
  • Monoclonal antibodies

Biosimilars and Biobetters

Advanced Therapy products Manufacturing

  • Cell Therapy producs
  • Tissue Engineering products
  • Culture media
  • Biomaterials (scaffolds and membranes)
Areas of interest for future collaborations
  • Development and Manufacturing of New Biological entities
  • Development and Manufacturing of BiosimilarsCooperation in National and International grants
  • Development of Industrial processes
  • Development of new Technologies and Manufacturing platforms